首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Comparison of exenatide with biphasic insulin aspart 30 on glucose variability in type 2 diabetes: study protocol for a randomized controlled trial
【2h】

Comparison of exenatide with biphasic insulin aspart 30 on glucose variability in type 2 diabetes: study protocol for a randomized controlled trial

机译:艾塞那肽与双相胰岛素30的比较对2型糖尿病患者血糖变异性的影响:一项随机对照试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundApart from the mean level of glycemic control, the extent of glucose excursions is another important issue to consider in type 2 diabetes mellitus (T2DM) management. Studies have showed that fluctuations of glucose seem to have more deleterious effects than sustained hyperglycemia in the development of diabetic complications as acute glucose swings activate the oxidative stress. However, until now, no randomized controlled trials have been conducted with the primary aim to evaluate glycemic fluctuation in the comparison between twice-daily exenatide and other treatment paradigms (for example, biphasic insulin aspart 30).
机译:背景除平均血糖控制水平外,葡萄糖偏移的程度是2型糖尿病(T2DM)管理中要考虑的另一个重要问题。研究表明,在糖尿病并发症的发展过程中,葡萄糖的波动似乎比持续的高血糖更具有害作用,因为急性葡萄糖波动会激活氧化应激。但是,到目前为止,还没有进行旨在评估每日两次艾塞那肽与其他治疗范例(例如,双相胰岛素aspart 30)之间血糖波动的主要随机对照试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号